Dr. Shekar Patil is a well-experienced medical oncologist, and his expertise expands to several areas like conventional and high-dose radiotherapy for solid and haematological malignancies, intraperitoneal chemotherapy for advanced ovarian cancers, concurrent radiation and chemotherapy for carcinoma, and bone marrow transplantation. His other areas of specialisation include oral recombination of human lactoferrin with carboplatin chemotherapy in gynaecological malignancies and the treatment of lymphoma and acute leukaemia. 

• FDG-PET Metabolic Vs CT Anatomical Monitoring of Tumour Response to Anterior Chemotherapy in Breast Carcinoma - The Uncertainties. Cancer Therapy & Oncol Int J. 2021; 19(1): 556003.
• Landscape of clinically actionable mutations in breast cancer 'A cohort study'. Transl Oncol. 2021 Jan;14(1):100877.
• Long-term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3-years follow-up study. J Oral Pathol Med. 2020 Sep;49(8):803-808.
• Circulating tumour cells in head and neck cancers: Biological insights. J Oral Pathol Med. 2020 Oct;49(9):842-848.
• Palbociclib in hormone-positive metastatic breast cancer: A real-world multicentre Indian experience.
• Journal of Clinical Oncology 38(15_suppl):e13057-e13057 (2020).
• Clinical Profile of Carcinoma Breast Patients Treated with Trastuzumab: A Single Centre Study. Advances in Breast Cancer Research 09(04):110-118. (2020).